BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29885819)

  • 1. Patterns of clustering of the metabolic syndrome components and its association with coronary heart disease in the Multi-Ethnic Study of Atherosclerosis (MESA): A latent class analysis.
    Riahi SM; Moamer S; Namdari M; Mokhayeri Y; Pourhoseingholi MA; Hashemi-Nazari SS
    Int J Cardiol; 2018 Nov; 271():13-18. PubMed ID: 29885819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clustering and combining pattern of metabolic syndrome components among Iranian population with latent class analysis.
    Abbasi-Ghahramanloo A; Soltani S; Gholami A; Erfani M; Yosaee S
    Med J Islam Repub Iran; 2016; 30():445. PubMed ID: 28210610
    [No Abstract]   [Full Text] [Related]  

  • 3. Sex- specific clustering of metabolic syndrome components and incidence of cardiovascular disease: A latent class analysis in a population-based cohort study.
    Ahanchi NS; Hadaegh F; Azizi F; Khalili D
    J Diabetes Complications; 2021 Jul; 35(7):107942. PubMed ID: 33965337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of metabolic syndrome among diverse Hispanics/Latinos living in the United States: Latent class analysis from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Arguelles W; Llabre MM; Sacco RL; Penedo FJ; Carnethon M; Gallo LC; Lee DJ; Catellier DJ; González HM; Holub C; Loehr LR; Soliman EZ; Schneiderman N
    Int J Cardiol; 2015 Apr; 184():373-379. PubMed ID: 25745986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis.
    Ong KL; McClelland RL; Allison MA; Kokkinos J; Wu BJ; Barter PJ; Rye KA
    Atherosclerosis; 2019 Feb; 281():200-206. PubMed ID: 30446181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
    Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
    J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical assessment of the metabolic syndrome definitions in the adult general population of the United States - the Multi-Ethnic Study of Atherosclerosis (MESA).
    Riahi SM; Fanoodi A; Shetty S; Hashemi-Nazari SS
    J Diabetes Metab Disord; 2023 Jun; 22(1):851-859. PubMed ID: 37255828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals.
    DeBoer MD; Filipp SL; Gurka MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.
    Pokharel Y; Sun W; Villareal DT; Selvin E; Virani SS; Ndumele CE; Hoogeveen RC; Coresh J; Boerwinkle E; Butler KR; Solomon SD; Pankow JS; Bozkurt B; Ballantyne CM; Nambi V
    Eur J Prev Cardiol; 2017 Apr; 24(6):628-638. PubMed ID: 27941157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modifying role of physical activity in the cross-sectional and longitudinal association of health-related quality of life with physiological functioning-based latent classes and metabolic syndrome.
    Cerletti P; Keidel D; Imboden M; Schindler C; Probst-Hensch N
    Health Qual Life Outcomes; 2020 Oct; 18(1):345. PubMed ID: 33081800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease.
    Zhang Y; Hong J; Gu W; Gui M; Chen Y; Zhang Y; Chi Z; Wang W; Li X; Ning G
    Endocrine; 2009 Oct; 36(2):233-8. PubMed ID: 19618299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and metabolic syndrome: from clustering to additional utility in prediction of coronary heart disease.
    Esteghamati A; Hafezi-Nejad N; Zandieh A; Sheikhbahaei S; Ebadi M; Nakhjavani M
    J Cardiol; 2014 Oct; 64(4):290-6. PubMed ID: 24631466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
    Ramezankhani A; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and all-cause and coronary heart disease (CHD) mortality: analysis of the U.S. National Health and Nutrition Examination Survey (NHANES).
    Oye-Somefun A; Kuk JL; Ardern CI
    BMC Cardiovasc Disord; 2021 Jul; 21(1):352. PubMed ID: 34311708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study.
    Ahanchi NS; Hadaegh F; Alipour A; Ghanbarian A; Azizi F; Khalili D
    Sci Rep; 2019 Feb; 9(1):1572. PubMed ID: 30733469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA).
    Nasir K; Budoff MJ; Wong ND; Scheuner M; Herrington D; Arnett DK; Szklo M; Greenland P; Blumenthal RS
    Circulation; 2007 Aug; 116(6):619-26. PubMed ID: 17646582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9 years follow-up of the tehran lipid and glucose study.
    Hadaegh F; Mohebi R; Cheraghi L; Tohidi M; Moghaddam NB; Bozorogmanesh M; Sheikholeslami F; Azizi F
    Stroke; 2012 Jun; 43(6):1669-71. PubMed ID: 22382161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study.
    Mani P; Ren HY; Neeland IJ; McGuire DK; Ayers CR; Khera A; Rohatgi A
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1(Suppl 1):S175-S179. PubMed ID: 27993539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and C-reactive protein among cardiology patients.
    Chapidze G; Dolidze N; Enquobahrie DA; Kapanadze S; Latsabidze N; Williams MA
    Arch Med Res; 2007 Oct; 38(7):783-8. PubMed ID: 17845899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and its individual components with mortality among patients with coronary heart disease.
    Chen Q; Zhang Y; Ding D; Li D; Xia M; Li X; Yang Y; Li Q; Hu G; Ling W
    Int J Cardiol; 2016 Dec; 224():8-14. PubMed ID: 27599384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.